SURFACE ABLATION
[/caption]Orca Surgical introduced its patented Epi-Clearâ„¢ device and a new treatment paradigm, EBKâ„¢ (Epi Bowman’s Keratectomy) at the ESCRS winter meeting in Prague. “Fifteen years of experience in refractive surgery and over 40,000 surgeries has led us to the conclusion that when it comes to safety, surface ablation is the only choice for refractive surgery,†said Yariv Bar-On, CEO at Orca Surgical. “Market research indicates strong growth in the number of surface ablation procedures performed each year. We believe we have developed the ultimate surgical tool for this purpose.â€
www.orcasurgical.com
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.